– Seqera Labs, a Barcelona-based data orchestration and workflow platform tailored to help scientists and engineers order and gain insights from cloud-based genomic data troves, as well as to tackle other life science applications that involve harnessing complex data from multiple locations, has raised $5.5 million in seed funding.
– Talis Capital and Speedinvest co-led this round, with participation also from previous backer BoxOne Ventures and a grant from the Chan Zuckerberg Initiative.

– Revelio Labs announced its seed capital raise of $4.0m.
– The round was led by Barclays and K20 Fund, with additional funding from NYU Ventures, BDMI, BoxOne Ventures, DataFrame Ventures, 840 Venture Partners and industry veterans, including Michael Recce and Jeremy Baksht, and values Revelio Labs at a $29m.
– The capital will be used to expand Revelio Labs’ offering beyond investment management, to corporate HR and strategy.

– AXONIS secured an additional $5m in funding.
– The round was led by Alexandria Venture Investments with participation by R3 Bio, BoxOne Ventures and Civilization Ventures and two leading spinal cord injury non-profit foundations, the Christopher & Dana Reeve Foundation and Spinal Research.
– The new investment will support AXONIS’ next development phase as it continues to advance its novel neuromodulating technology into the clinic.
– The Company’s pipeline includes neuron-reviving therapeutics that enable an intrinsic ability of central nervous system (CNS) neurons to resist degeneration, restore excitation/inhibition balance and regenerate.
– The Company’s targeted indications include spinal cord injury and epilepsy, as well as broader neurodegenerative conditions.